Back
Arcutis Biotherapeutics Quote, Financials, Valuation and Earnings
Sponsored
ARQT
Sponsored
Free, 30-minute video on trading overnight options for big gains
Get access to this 30-minute training free here.
Buy
62
ARQT
Arcutis Biotherapeutics
Last Price:
10.49
Seasonality Move:
-17.15%
7 Day Trial
ALL ACCESS PASS
$
7
This New Idea is Set to Shock the World
Click here to learn all the details.Arcutis Biotherapeutics Price Quote
$10.49
Arcutis Biotherapeutics Key Stats
Buy
62
Arcutis Biotherapeutics (ARQT)
is a Buy
Day range:
$9.43 - $10.53
52-week range:
$1.76 - $13.17
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
8.06
P/B ratio:
5.4%
Volume:
3M
Avg. volume:
2.8M
1-year change:
12.92%
Market cap:
$1.2B
Revenue:
$59.6M
EPS:
$-2.93
How Much Does Arcutis Biotherapeutics Make?
-
How Much Are Arcutis Biotherapeutics's Sales Annually?
ARQT Revenues are $59.6M -
How Much Profit Does Arcutis Biotherapeutics's Make A Year?
ARQT net income is -$262.1M
Is Arcutis Biotherapeutics Growing As A Company?
-
What Is Arcutis Biotherapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 16.82% -
What Is Arcutis Biotherapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Arcutis Biotherapeutics Stock Price Performance
-
Did Arcutis Biotherapeutics Stock Go Up Last Month?
Arcutis Biotherapeutics share price went up by 31.62% last month -
Did ARQT's Share Price Rise Over The Last Year?
ARQT share price rose by 12.92% over the past 1 year
What Is Arcutis Biotherapeutics 52-Week High & Low?
-
What Is Arcutis Biotherapeutics’s 52-Week High Share Price?
Arcutis Biotherapeutics has traded as high as $13.17 over the past 52 weeks -
What Is Arcutis Biotherapeutics’s 52-Week Low Share Price?
Arcutis Biotherapeutics has traded as low as $1.76 over the past 52 weeks
Arcutis Biotherapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Arcutis Biotherapeutics?
-
How Much Debt Does Arcutis Biotherapeutics Have?
Total long term debt quarterly is $202.8M -
How Much Cash Does Arcutis Biotherapeutics Have?
Cash and short term investments quarterly total is $403.9M -
What Is Arcutis Biotherapeutics’s Book Value Per Share?
Book value per share is 1.95
Is Arcutis Biotherapeutics Cash Flow Positive?
-
What Is ARQT Cash Flow From Operations?
Cash flow from operations (TTM) is -$198.3M -
What Is Arcutis Biotherapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $263M -
What Is Arcutis Biotherapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $43.8M
Arcutis Biotherapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
ARQT return on invested capital is -68.61% -
What Is Arcutis Biotherapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -59.96% -
What Is ARQT Return On Equity?
ROE is a measure of profitability and is -187.25%
Arcutis Biotherapeutics Earnings Date & Stock Price
-
What Is Arcutis Biotherapeutics's Stock Price Today?
A single share of ARQT can be purchased today for 10.49 -
What Is Arcutis Biotherapeutics’s Stock Symbol?
Arcutis Biotherapeutics trades on the nasdaq under the ticker symbol: ARQT -
When Is Arcutis Biotherapeutics’s Next Earnings Date?
The next quarterly earnings date for Arcutis Biotherapeutics is scheduled on August 8, 2024 -
When Is ARQT's next ex-dividend date?
Arcutis Biotherapeutics's next ex-dividend date is July 6, 2024 -
How To Buy Arcutis Biotherapeutics Stock?
You can buy Arcutis Biotherapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Arcutis Biotherapeutics Competitors
-
Who Are Arcutis Biotherapeutics's Competitors?
Below is a list of companies who compete with Arcutis Biotherapeutics or are related in some way:
Arcutis Biotherapeutics Dividend Yield
Data Unavailable
Arcutis Biotherapeutics Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 56.16% |
Revenue: | 1682.42% | 227.4% |
Analyst Recommendations
Buy Recommendations: | 3 |
---|---|
Hold Recommendations: | 2 |
Sell Recommendations: | 0 |
Price Target: | 19.00 |
Upside from Last Price: | 81.12% |